VS HIV-1 integrase genotyping kit, RUO

Ended Awarded Last action

Contract number
W81XWH21F0062
Awardee
Awarding agency
Obligated
$41,034

Award facts

Opportunity
Contract value 100% obligated
$41,034.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rosemont, IL 60018, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$6,672
Original award $47,706

About this award

The Department of the Army Medical Command awarded Abbott Molecular Inc., a subsidiary of Abbott Laboratories, a $41,034 firm fixed price call against the Biomedical Product and Services Agreement (BPA) to deliver a VS HIV-1 INTEGRASE GENOTYPING KIT for research use only. Performance will occur in Des Plaines, Illinois. The kit will support the Medical Command's efforts to conduct HIV genotyping to inform treatment decisions. No set-aside provisions were applied to this award, which must be completed by May 25, 2021.

Quick answers

Who was awarded contract W81XWH21F0062?

W81XWH21F0062 was awarded to Abbott Molecular Inc. by Medical Command (Department of the Army) on January 11, 2021.

How much is contract W81XWH21F0062 worth?

The government has obligated $41,034 on W81XWH21F0062.

Is contract W81XWH21F0062 an order under another contract?

Yes. W81XWH21F0062 is a BPA call under W81XWH19A0009, a blanket purchase agreement.

Was contract W81XWH21F0062 competed?

The extent of competition for W81XWH21F0062 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award